卡姆雷利祖马布诱导的口服液化物反应与亚皮质CD4+T细胞透
Xiangjian Wang1, Tao Fu2, Weilian Sun1
1Department of Oral Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
概括
卡姆雷利祖马布是一种抗PD-1抗体,可以引起罕见的口服液化物反应 (OLR). 这一案例表明CD4+T细胞,而不是CD8+细胞,可能在camrelizumab诱导的OLR病变发生中发挥作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 卡姆雷利祖马布是一种用于各种癌症的抗编程细胞死亡-1 (PD-1) 抗体.
- 与免疫相关的不良事件,特别是CD4+ T细胞介导反应,在使用PD-1抑制剂时越来越多地报告.
- 口腔状体反应 (OLR) 是抗PD-1疗法的罕见副作用,通常涉及CD8+T细胞.
相关概念视频
Allergic Drug Reactions
870
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
870
Allergic Reactions
27.6K
Overview
27.6K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

